Cargando…
Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM
Colorectal cancer (CRC) is the third most common cancer worldwide, and liver metastasis presents a major cause of CRC-associated death. Extensive genomic analysis has provided valuable insight into the pathogenesis and progression of CRC; however, a comprehensive proteogenomic characterization of CR...
Autores principales: | Ma, Yu-Shui, Wu, Zhi-Jun, Zhang, Hong-Wei, Cai, Bo, Huang, Tao, Long, Hui-Deng, Xu, Hong, Zhao, Yong-Zhong, Yin, Yu-Zhen, Xue, Shao-Bo, Li, Liu, Liu, Cheng-Lin, Xie, Ru-Ting, Tian, Lin-Lin, Liu, Ji-Bin, Wu, Xu-Ming, Fu, Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579909/ https://www.ncbi.nlm.nih.gov/pubmed/31236441 http://dx.doi.org/10.1016/j.omto.2019.04.008 |
Ejemplares similares
-
Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC
por: Huang, Ruizhen, et al.
Publicado: (2022) -
Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression
por: Weng, Mei-lin, et al.
Publicado: (2020) -
Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1
por: Xi, Hongkang, et al.
Publicado: (2010) -
ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
por: Wang, Da, et al.
Publicado: (2023) -
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
por: Kanmalar, M., et al.
Publicado: (2022)